Skip to main content
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. — Investor Relations & Filings

Ticker · SANA ISIN · US7995661045 US Manufacturing
Filings indexed 362 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country US United States of America
Listing US SANA

About Sana Biotechnology, Inc.

https://sana.com/

Sana Biotechnology, Inc. is a company that develops engineered cells as medicines to address the underlying causes of disease. Its core strategy involves two primary platforms: in vivo therapies designed to repair and control genes within a patient's existing cells, and ex vivo therapies that replace missing or damaged cells with new, functional ones. The company utilizes proprietary technologies, such as engineered fusogen proteins, for the targeted delivery of therapeutics. Sana's pipeline is focused on advancing drug candidates for a range of diseases, including diabetes, B-cell cancers, and B-cell related autoimmune disorders.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-15 English
S-8 - Sana Biotechnology, Inc. (0001770121) (Filer)
Registration Form
2026-05-11 English
ARS - Sana Biotechnology, Inc. (0001770121) (Filer)
Annual Report
2026-04-24 English
DEF 14A - Sana Biotechnology, Inc. (0001770121) (Filer)
Proxy Solicitation & Information Statement
2026-04-24 English
8-K - Sana Biotechnology, Inc. (0001770121) (Filer)
Regulatory Filings
2026-04-24 English
424B5 - Sana Biotechnology, Inc. (0001770121) (Filer)
Prospectus
2026-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.